Aug 27 (Reuters) - Specialty pharmaceutical company Akorn Inc will buy rival Hi-Tech Pharmacal Co Inc for $640 million in cash to expand its eye drug portfolio to other dosage forms such as oral ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback